
Neurofibromatosis Type 1 (NF1) Drug Development Gains Momentum Amid Growing Need for Safer, More Effective Therapies
NF1 drug development accelerates with novel treatments aiming to surpass current MEK inhibitors in efficacy, safety, and patient-friendly delivery. AUSTIN, TX, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- In the realm of rare genetic …